Studies like MIndMed's are moving closer to proving its benefits. In our podcast, we delve into LSD's universe and ...
Today, an alternative approach is the use of very low doses, or “microdoses” of psychedelic drugs. Anecdotal reports claim that repeated ingestion of LSD microdoses improves depression ratings without ...
Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks ...
Psychotropic drugs are all the rage now as a potential treatment of brain diseases. Examples are ketamine and psilocybin for depression and PTSD. More recently, a single dose of LSD was found to have ...
A single dose of LSD can cut anxiety in half within weeks, according to the results of a new study conducted by a biopharmaceutical company. MindMed, a clinical-stage company that develops novel ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a phase IIb study, a single dose of an investigational ...
A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc ...
In a clinical trial by Mind Medicine Inc., a pioneering biopharmaceutical company, a single dose of LSD has shown promising results in providing immediate and sustained relief from generalized ...
VANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ...